EVOFEM BIOSCIENCES, INC. (EVFM) Free cash flow 2016–2025
EVOFEM BIOSCIENCES, INC. (EVFM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.0MFY2025 · since FY2016: -$24.9M → -$2.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.0M | +48.8% |
| FY2024 | -$3.9M | +56.5% |
| FY2023 | -$9.0M | +87.3% |
| FY2022 | -$70.8M | +52.7% |
| FY2021 | -$149.6M | -39.7% |
| FY2020 | -$107.1M | -93.8% |
| FY2019 | -$55.3M | +2.2% |
| FY2018 | -$56.5M | -193.6% |
| FY2017 | -$19.2M | +22.7% |
| FY2016 | -$24.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice